
OtherApr 4, 2026, 07:41 AM
Arcadia Biosciences Dismisses Deloitte & Touche as Independent Auditor
AI Summary
Arcadia Biosciences dismissed Deloitte & Touche as its independent registered public accounting firm on March 30, 2026. The decision was made by the audit committee of the board of directors. While Deloitte's audit reports did not contain adverse opinions, the company had previously identified material weaknesses in its internal control over financial reporting.
Key Highlights
- Deloitte's audit reports for 2024 and 2025 did not contain adverse opinions or disclaimers.
- The audit reports included an explanatory paragraph regarding the company's ability to continue as a going concern.
- Arcadia Biosciences identified material weaknesses in its internal control over financial reporting as of December 31, 2025.
Price Impact
More from RKDA